The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression

被引:202
作者
Urizar, NL [1 ]
Dowhan, DH [1 ]
Moore, DD [1 ]
机构
[1] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA
关键词
D O I
10.1074/jbc.M007998200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bile acids facilitate the absorption of dietary lipids and fat-soluble vitamins and are physiological ligands for the farnesoid X-activated receptor (FXR), a member of the nuclear hormone receptor superfamily, FXR functions as a heterodimer with the retinoid X receptor and in the presence of ligand, the heterodimer binds to specific DNA sequences in the promoters of target genes to regulate gene transcription. Phospholipid transfer protein (PLTP) has been identified as a possible target gene for FXR because the human promoter contains a potential FXR response element, an inverted repeat in which consensus receptor-binding hexamers are separated by one nucleotide (inverted repeat-1). PLTP is essential in the transfer of very low density lipoprotein phospholipids into high density lipoprotein (Jiang, X, C., Bruce, C., Mar, J., Lin, M., Ji, Y., Francone, O. L., and Tall, A. R. (1999) J. Clin. Invest. 103, 907-914), Here we report the regulation of PLTP gene expression by FXR and bile acids. In CV-1 cells, cotransfection of FXR and the retinoid X receptor resulted in bile acid-dependent transactivation of a luciferase reporter construct containing the human PLTP promoter. Mutation analysis demonstrated that the inverted repeat-1 (IR-l) in the PLTP promoter is required for this transactivation. Finally, we demonstrate that bile acids are able to regulate PLTP gene expression in vivo. Mice fed a chow diet supplemented with bile acid showed increased hepatic PLTP mRNA levels. These results suggest that FXR may play a role in high density lipoprotein metabolism via the regulation of PLTP gene expression.
引用
收藏
页码:39313 / 39317
页数:5
相关论文
共 28 条
[1]   FUNCTIONAL EXPRESSION OF HUMAN AND MOUSE PLASMA PHOSPHOLIPID TRANSFER PROTEIN - EFFECT OF RECOMBINANT AND PLASMA PLTP ON HDL SUBSPECIES [J].
ALBERS, JJ ;
WOLFBAUER, G ;
CHEUNG, MC ;
DAY, JR ;
CHING, AFT ;
LOK, S ;
TU, AY .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1995, 1258 (01) :27-34
[2]  
Auwerx J, 1999, CELL, V97, P161
[3]   Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport [J].
Bruce, C ;
Chouinard, RA ;
Tall, AR .
ANNUAL REVIEW OF NUTRITION, 1998, 18 :297-330
[4]   Farnesoid X receptor responds to bile acids and represses cholesterol 7α-hydroxylase gene (CYP7A1) transcription [J].
Chiang, JYL ;
Kimmel, R ;
Weinberger, C ;
Stroup, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (15) :10918-10924
[5]   SPURIOUS ELEVATION OF SERUM HIGH-DENSITY-LIPOPROTEIN CHOLESTEROL IN PATIENTS WITH CHOLESTATIC LIVER-DISEASES [J].
CHIBA, H ;
OSAKA, T ;
IWASAKI, N ;
SUZUKI, H ;
AKIZAWA, K ;
FUJISAWA, S ;
INTOH, S ;
WATANABE, M ;
YOSHIDA, J ;
MATSUNO, K ;
MITAMURA, T ;
KOBAYASHI, K .
BIOCHEMICAL MEDICINE AND METABOLIC BIOLOGY, 1991, 46 (03) :329-343
[6]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[7]   CHANGES IN HUMAN HIGH-DENSITY LIPOPROTEINS IN PATIENTS WITH EXTRA-HEPATIC BILIARY OBSTRUCTION [J].
COULHON, MP ;
TALLET, F ;
YONGER, J ;
AGNERAY, J ;
RAICHVARG, D .
CLINICA CHIMICA ACTA, 1985, 145 (02) :163-172
[8]   IDENTIFICATION OF A NUCLEAR RECEPTOR THAT IS ACTIVATED BY FARNESOL METABOLITES [J].
FORMAN, BM ;
GOODE, E ;
CHEN, J ;
ORO, AE ;
BRADLEY, DJ ;
PERLMANN, T ;
NOONAN, DJ ;
BURKA, LT ;
MCMORRIS, T ;
LAMPH, WW ;
EVANS, RM ;
WEINBERGER, C .
CELL, 1995, 81 (05) :687-693
[9]   Identification of a bile acid-responsive element in the human ileal bile acid-binding protein gene -: Involvement of the farnesoid X receptor/9-cis-retinoic acid receptor heterodimer [J].
Grober, J ;
Zaghini, I ;
Fujii, H ;
Jones, SA ;
Kliewer, SA ;
Willson, TM ;
Ono, T ;
Besnard, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (42) :29749-29754
[10]  
GYLLING H, 1995, HEPATOLOGY, V21, P89, DOI 10.1002/hep.1840210116